IBB iShares Biotechnology ETF chart & analysis

Conviction 55Scan · Fri, Nov 6, 2026

iShares Biotechnology ETF (IBB) closed at $213.63 (+1.73%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 53, RS Rating 89, -3.9% from its 52-week high, +26.6% year to date.

IBB$213.63+1.73%

ResistanceSupportVol 14

Loading chart…

iShares Biotechnology ETF

Price213.63

Change+1.73%

Gap-0.31%

Rel volume1.27×

Avg volume1.86M

Avg $ vol393.13M

SMA 20210.36

SMA 50208.46

SMA 200185.80

Price vs 50+2.52%

Price vs 200+15.03%

MA stackbullish

50/200 cross—

Supertrendup · 203.87

RSI (14)53

MACD hist0.24

MACD cross—

Stoch %K / %D51 / 61

ADX (14)17

+DI / −DI24 / 18

RSI divergence—

MACD divergence—

ATR %2.63%

ADR %2.49%

52w high222.29

52w low154.98

From 52w high-3.86%

Above 52w low+37.90%

New 52w highNo

SqueezeOff

Bollinger width10.74%

%B0.65

Donchian pos63.14%

Donchian high222.29

Donchian low199.04

AVWAP (52w high)215.85

vs AVWAP high-0.99%

AVWAP (52w low)182.16

vs AVWAP low+17.33%

OBV trendFlat

Chaikin MF (20)-0.06

Today vs 20d1.27×

Avg vol (14d)2.08M

Avg vol (20d)1.86M

Avg $ vol (20d)393.13M

Market cap—

RS Rating89 / 99

RS 3m (vs SPY)+11.72%

RS 6m (vs SPY)+26.06%

RS line new highYes

Trend template8/8

Technical rank85.9

1 week-1.79%

1 month+6.60%

3 months+6.85%

6 months+25.76%

1 year+35.00%

YTD+26.63%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

Industry—

ExchangeXNAS

Shares out46.95M

Employees—

ListedMon, Feb 5, 2001

Free float—

Float %—

Short interest—

Days to cover—

Short volume50.5%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction55 / 100

Pattern quality—

Tech rank85.9 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance221.78

Support197.96

Days since event—

Candle confirm—

IBB technical analysis

Trend

IBB is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 2.5% above the 50-day ($208.46) and 15.0% above the 200-day ($185.80). ADX(14) at 17 points to a weak trend — more range than direction. It meets 8 of 8 trend-template criteria.

Momentum

RSI(14) is 53, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 89 puts its weighted 12-month performance ahead of about 89% of the US market, and its RS line is at a new high.

Volume and volatility

Volume on the latest session ran 1.3× its 20-day average. It trades about $393.1M a day on average. ATR(14) is $5.62, 2.6% of price — its typical daily range. Chaikin Money Flow (-0.06) shows distribution.

Key levels

The chart pattern's support is $197.96 and its resistance $221.78. The 52-week range is $154.98 to $222.29; price is 3.9% below the high and 37.9% above the low. The VWAP anchored at the 52-week high is $215.85, above price.

Performance

IBB returned -1.8% (1 week), +6.6% (1 month), +6.9% (3 months), +25.8% (6 months), +35.0% (1 year), +26.6% (year to date).

About iShares Biotechnology ETF

Listed 2001

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.